PRE-CLINICAL STUDIES

Pre-Clinical Studies intro text. Ciatiatur autem quisita serum accae commoluptas qui dolest

In Vivo

Mus ni aute voluptat restior repudit quibeatque vide nosto quissimporro cum estem quiducid quae lam adiati nusanis volupis siminum Mus ni aute voluptat restior repudit quibeatque vide nosto quissimporro cum estem quiducid quae lam adiati nusanis volupis siminum.

•Mouse models of rhinovirus-induced exacerbations of asthma
•Mouse models of rhinovirus-induced exacerbations of COPD
•Mouse models of rhinovirus, RSV and influenza virus infection
•Ovalbumin and house dust mite asthma models
•Elastase/LPS COPD models

In Vitro

Cell Types

BRONCHIAL EPITHELIAL CELLS

•Cell lines, eg A549, BEAS-2B, H292, others
•Primary bronchial epithelial cells from asthma, COPD, healthy subjects, smokers, older persons
•Submerged cultures
•Air liquid interface cultures

Monocytes/macrophages

•THP-1 cells
•Primary cells (PBMCs, BAL cells) from asthma, COPD, healthy subjects

Infectious agents

Get in touch

Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.

Our team

Virtus’s Founders have worked together since 2001 in various academic and commercial settings.

Professor Sebastian Johnston

Director & Chief Medical Officer

Dr Michael Edwards

Managing & Scientific Director

Meet the full team